30 terminated. 30 Phase 2, 5 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 30 | Terminated 30 |
| Phase 1 | 5 | Terminated 5 |
| Phase 3 | 2 | Terminated 2 |
Follow Hyperinsulinism: new trials by email Literature Review of Hyperinsulinism trials Research Report on Hyperinsulinism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome MitoQ (mitoquinol mesylate), Placebo - Lower Urinary Tract Symptoms, Overactive Bladder Syndrome | Phase 2 | Terminated | Iman Al-Naggar, PhD | 20 | 2024-04-03 | 2026-05-01 |
| A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM ALN-KHK, Placebo - Type 2 Diabetes Mellitus (T2DM) | Phase 1 / Phase 2 | Terminated | Alnylam Pharmaceuticals | 49 | 2023-03-10 | 2025-05-07 |
| Intranasal Insulin in Frontotemporal Dementia (FTD) Novolin-R insulin - Frontotemporal Dementia, Behavioral Variant | Phase 2 | Terminated | HealthPartners Institute | 3 | 2019-09-09 | 2023-10-27 |
| Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas Humalog, Novolog, BC222 insulin lispro - Type 1 Diabetes Mellitus | Phase 2 / Phase 3 | Terminated | Massachusetts General Hospital | 20 | 2019-03-19 | 2022-12-09 |
| Insulin Treatment in Diabetic Older People With Heart Failure. Insulin - Heart Failure, Diabetes Mellitus, Type 2 | Phase 2 | Terminated | Mario Negri Institute for Pharmacological Research | 10 | 2018-11-08 | 2019-11-18 |
| Neuro Biomarkers of Smoking Behavior Novolin R - Smoking Cessation | Phase 2 | Terminated | University of Illinois at Chicago | 4 | 2018-09-12 | 2021-03-02 |
| Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide Diazoxide, Placebo - Diabetes Mellitus, Type 2, Glucose, High Blood | Phase 2 | Terminated | Meredith Hawkins | 37 | 2018-06-12 | 2025-05-31 |
| Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression. UCMSCs, BMMSCs, Placebo - Endothelial Dysfunction, Metabolic Syndrome | Phase 1 / Phase 2 | Terminated | Joshua M Hare | 14 | 2018-04-12 | 2022-11-08 |
| Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk Rosuvastatin Calcium, Placebo Oral Tablet, Coenzyme Q10 - Spinal Cord Injuries, Osteoporosis | Phase 2 | Terminated | Dr. B. Catharine. Craven | 8 | 2018-02-26 | 2026-04-13 |
| Study to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metabolic Syndrome PBI-4050, Placebo - Type 2 Diabetes Mellitus, Metabolic Syndrome | Phase 2 | Terminated | Liminal BioSciences Ltd. | 104 | 2017-05-29 | 2020-12-08 |
| Nitrite Infusion in Islet Cell Transplantation Control, Pre-Isolation Infusion, Post-Isolation Infusion - Diabetes | Phase 2 | Terminated | University of Alabama at Birmingham | 4 | 2017-05-07 | 2020-10-29 |
| Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus Mifepristone 600 mg daily, Placebo - Type 2 Diabetes Mellitus, Insulin Resistance | Phase 2 | Terminated | Charles Drew University of Medicine and Science | 8 | 2017-02-03 | 2023-05-18 |
| Dose-response Study of Carduus Marianus in Centesimal Scale for Dyslipidemia in Climacteric Overweighed or Obese Women. Carduus marianus 6cH, Carduus marianus 12cH, Carduus marianus 30cH - Dyslipidemia, Menopause | Phase 2 | Terminated | Hospital Nacional Homeopático, Mexico | 62 | 2016-02-01 | 2019-02-28 |
| The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects Eritoran, D5W - Insulin Sensitivity | Phase 2 | Terminated | The University of Texas Health Science Center at San Antonio | 15 | 2015-01-01 | 2020-03-04 |
| Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate Metformin, Placebo - Prostatic Neoplasm | Phase 2 | Terminated | AHS Cancer Control Alberta | 83 | 2014-09-01 | 2024-01-30 |
| Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease Roflumilast, Placebo - Chronic Obstructive Pulmonary Disease, Metabolic Syndrome | Phase 2 | Terminated | Laval University | 14 | 2013-02-01 | 2014-11-11 |
| Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin Metformin, Sugar pill - Insulin Resistance, Hypermetabolism | Phase 2 / Phase 3 | Terminated | The University of Texas Medical Branch, Galveston | 36 | 2012-11-01 | 2019-11-29 |
| The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance Fish Oil (Omega-3 Fatty Acids) - Endothelial Dysfunction, Insulin Resistance | Phase 2 | Terminated | University of California, San Francisco | 5 | 2011-09-01 | 2013-11-07 |
| Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity Metformin, Orlistat, Topiramate - Obesity, Metabolic Syndrome X | Phase 2 | Terminated | University of Iowa | 128 | 2011-03-01 | 2026-03-12 |
| Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT) Sodium Octanoate Breath Test - Metabolic Syndrome, Nonalcoholic Fatty Liver Disease | Phase 2 | Terminated | Virginia Commonwealth University | 61 | 2011-02-01 | 2015-07-28 |
Showing 20 of 30. Sign in to see all of them.
Insulin Resistance (19) · Metabolic Syndrome (11) · Diabetes Mellitus, Type 2 (9) · Obesity (5) · Diabetes Mellitus (3) · Diabetes Mellitus, Type 1 (2) · Dyslipidemias (2) · Glucose Metabolism Disorders (2) · Overweight (2) · Autoimmune Diseases (1) · Burns (1) · Congenital Hyperinsulinism (1) · Enterovirus Infections (1) · Glucose Intolerance (1) · Heart Failure (1)
Nutritional and Metabolic Diseases (30) · Metabolic Diseases (29) · Glucose Metabolism Disorders (28) · Endocrine System Diseases (12) · Insulin Resistance (10) · Diabetes Mellitus (9) · Pathological Conditions, Signs and Symptoms (9) · Signs and Symptoms (7) · Body Weight (6) · Cardiovascular Diseases (5) · Nutrition Disorders (5) · Overnutrition (5) · Vascular Diseases (4) · Nervous System Diseases (3)
Insulin (5) · Metformin (3) · Bosentan (1) · Calcium Carbonate (1) · Clomiphene (1) · Cyclosporine (1) · Diazoxide (1) · Diet (1) · E5564 (1) · Exercise (1) · Fatty Acids, Omega-3 (1) · Fish Oils (1) · Glucagon-Like Peptide 1 (1) · Glycemic Control (1) · Incretins (1)
AHS Cancer Control Alberta (1) · Albert Einstein College of Medicine (1) · Alnylam Pharmaceuticals (1) · Charles Drew University of Medicine and Science (1) · Diva De Leon (1) · Dr. B. Catharine. Craven (1) · GlaxoSmithKline (1) · HealthPartners Institute (1) · Hospital Nacional Homeopático, Mexico (1) · Iman Al-Naggar, PhD (1) · Joshua M Hare (1) · Laval University (1) · Liminal BioSciences Ltd. (1) · Mario Negri Institute for Pharmacological Research (1) · Massachusetts General Hospital (1)
United States (21) · Canada (5) · Austria (1) · Brazil (1) · Italy (1) · Mexico (1) · Norway (1) · Spain (1)
Ajna Hamidovic, PharmD, MS (1) · Albert Feliu, MD PhD (1) · Arun J. Sanyal, M.D. (1) · B. Catharine Craven, BA, MD, FRCPC, MSc (1) · Blair Smith, MD (1) · Bruno Geloneze, MD, PhD (1) · Daniel T Stein, MD (1) · David N Herndon, MD (1) · Diva D De Leon, MD MSCE (1) · Emma del Carmen Macias-Cortes, PhD (1) · Gary L Pierce, PhD (1) · Giovanni Cizza, M.D. (1) · Gloria Bueno, MD, PhD (1)
PMID 19475464, PMID 21799479, PMID 22689694, PMID 23483886, PMID 23734252, PMID 24482677, PMID 36066991, PMID 39952695, PMID 41388232
2008 (1), 2016 (1), 2018 (1), P30AG067988 (1), R01DK061644 (1), R01DK069861 (1)